ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in BIOA — BioAge Labs, Inc.
CIK 1164508
BOSTON, MA
Position in BIOA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,537,038
New position
Shares Held
87,881
first reported quarter
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. BIOA ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,975,559 | $233,530,829 | |
| 2 | HLN |
Haleon plc
|
14,674,518 | $146,891,925 | |
| 3 | VTRS |
Viatris Inc
|
8,545,196 | $115,445,597 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,323,264 | $70,813,086 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,116,311 | $57,714,079 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
564,360 | $43,399,284 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
892,666 | $42,981,867 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
703,528 | $23,265,670 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,537,038 | 87,881 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||